598 research outputs found
A computer-based expert system for consultation on the use and interpretation of high-resolution electrocardiography
Androgenic Effect and Phytochimie of the Bark of Trunk of Buchholzia coriacea Engl. (Capparidaceae)
The testosterone is the main androgen produced by the testes among the males. Her absence is responsible for erectile dysfunction and the loss of the sexual performance. The aim of the present study is to evaluate the androgenic effect and to determine the profile phytochemestry of the barks of trunk of B. coriacea. Fifteen days after the castration, the animals left in group and, received the aqueous extract of B. coriacea (100, 250 and 500 mg/kg, p.o). The sexual parameters (mounts sexual, number of erections, number of ejaculations and the time of latency) have been valued, and compared, to the witnesses groups: water distilled (0,5 ml/100 mg, p.o) and Enanthate of testosterone (1 mg/mL, i.m). The dosage of the testosterone has been achieved by the technic of ELYSA analysis. The determination of the chemical families has been achieved by the technique of coloration in tubes. The aqueous extract of B. coriacea (100,250 and 500 mg/kg, p.o) has an effect androgenic because managed daily during 15 days, it provokes an increase of the rate plasmatic of the testosterone and the bodily weight of the rats, maintains the sexual parameters among the castrated rat, extract the number of ejaculations. The barks of trunk of B. coriacea would contain the stérols, the flavonoides, the saponosids that could be responsible for the sexual effects and androgénic observed. The aqueous extract of the plant would possess the properties androgenic would be to advise the patients presenting problems of masculine barrenness.
Keywords: Androgen - Phytochimie - Buchholzia - coriacea 
Low-abundance HIV species and their impact on mutational profiles in patients with virological failure on once-daily abacavir/lamivudine/zidovudine and tenofovir
Interference effects in isolated Josephson junction arrays with geometric symmetries
As the size of a Josephson junction is reduced, charging effects become
important and the superconducting phase across the link turns into a periodic
quantum variable. Isolated Josephson junction arrays are described in terms of
such periodic quantum variables and thus exhibit pronounced quantum
interference effects arising from paths with different winding numbers
(Aharonov-Casher effects). These interference effects have strong implications
for the excitation spectrum of the array which are relevant in applications of
superconducting junction arrays for quantum computing. The interference effects
are most pronounced in arrays composed of identical junctions and possessing
geometric symmetries; they may be controlled by either external gate potentials
or by adding/removing charge to/from the array. Here we consider a loop of N
identical junctions encircling one half superconducting quantum of magnetic
flux. In this system, the ground state is found to be non-degenerate if the
total number of Cooper pairs on the array is divisible by N, and doubly
degenerate otherwise (after the stray charges are compensated by the gate
voltages).Comment: 9 pages, 6 figure
Comparative gender analysis of the efficacy and safety of atazanavir/ritonavir and lopinavir/ritonavir at 96 weeks in the CASTLE study.
OBJECTIVES: To examine whether the overall results of the CASTLE study pertain to both genders, we analysed the efficacy and safety of atazanavir/ritonavir and lopinavir/ritonavir in 277 female and 606 male patients in the open-label, multinational trial over 96 weeks. The trial is registered with ClinicalTrials.gov, number NCT00272779.
METHODS: Treatment-naive patients aged ≥ 18 years with HIV-1 RNA ≥ 5000 copies/mL were randomized to receive either atazanavir/ritonavir 300/100 mg once daily or lopinavir/ritonavir 400/100 mg twice daily, with fixed-dose tenofovir/emtricitabine 300/200 mg once daily.
RESULTS: At week 96, confirmed virological response rates (HIV RNA \u3c50 copies\u3e/mL; intent-to-treat analysis) were higher in women and men receiving atazanavir/ritonavir than those receiving lopinavir/ritonavir and lower in women than men in both treatment arms (67% of women and 77% of men on atazanavir/ritonavir and 63% of women and 71% of men on lopinavir/ritonavir). These differences were not observed in the on-treatment analysis. Mean change in CD4 cell count from baseline to week 96 was 265 cells/mm(3) for women and 269 cells/mm(3) for men on atazanavir/ritonavir and 298 cells/mm(3) for women and 286 cells/mm(3) for men on lopinavir/ritonavir. Discontinuation rates were higher in women than men in each treatment arm (22% of women and 15% of men on atazanavir/ritonavir and 29% of women and 18% of men on lopinavir/ritonavir). In women and men, grade 2-4 nausea and diarrhoea were more frequent in the lopinavir/ritonavir group; jaundice and hyperbilirubinaemia occurred more frequently in the atazanavir/ritonavir group.
CONCLUSIONS: Once-daily atazanavir/ritonavir is an effective and well-tolerated therapeutic option for women and men with HIV-1 infection. The sex-based differences in response may be due to higher discontinuation rates in women
nu=1/2 quantum Hall effect in the Aharonov-Casher geometry in a mesoscopic ring
We study the effect of an electric charge in the middle of a ring of
electrons in a magnetic field such as . In the absence of the
central charge, a residual current should appear due to an Aharanov-Bohm
effect. As the charge varies, periodic currents should appear in the ring. We
evaluate the amplitude of these currents, as well as their period as the
central charge varies. The presence of these currents should be a direct
signature of the existence of a statistical gauge field in the
quantum Hall effect. Numerical diagonalizations for a small number of electrons
on the sphere are also carried out. The numerical results up to 9 electrons are
qualitatively consistent with the mean field picture.Comment: 23 pages,14 included postscript figures, submitted to Phys. Rev.
Possible realization of Josephson charge qubits in two coupled Bose-Einstein condensates
We demonstrate that two coupled Bose-Einstein condensates (BEC) at zero
temperature can be used to realize a qubit which is the counterpart of
Josephson charge qubits. The two BEC are weakly coupled and confined in an
asymmetric double-well trap. When the "charging energy" of the system is much
larger than the Josephson energy and the system is biased near a degeneracy
point, the two BEC represent a qubit with two states differing only by one
atom. The realization of the BEC qubits in realistic BEC experiments is briefly
discussed.Comment: 4 pages; comments are welcome / Corrected typos in Eq. (16); a note
adde
Development and validation of tele-health system for stroke rehabilitation
ABSTRACT Tele-rehabilitation refers to the use of information and communication technologies to provide rehabilitation services to people in their homes or other environments. The objective of this paper is to present the development, validation and usability testing of a low-cost, markerless full body tracking virtual reality system designed to provide remote rehabilitation of the upper extremity in patients who have had a stroke. The Methods and Results sections present the progress of our work on system development, system validations and a feasibility/usability study. We conclude with a brief summary of the initial stages of an intervention study and a discussion of our findings in the context of the next steps. The validation study demonstrated considerable accuracy for some outcomes (i.e., shoulder "pitch" angle, elbow flexion, trunk forward and side-to-side deviation). In addition positive responses were received from the clients who participated in the feasibility study. We are currently at the process of improving the accuracy of the system as well as conducting a randomized clinical trial to assess the effectiveness of the system to improve upper extremity function post-stroke
Cardiac angiography without cine film: Erecting a “Tower of Babel” in the cardiac catheterization laboratory
- …